Adduct Analys

Adduct Analys AB was founded in 2004 to commercialize technology developed at the Department of Environmental Chemistry at Stockholm University, Sweden. 

The company’s main focus is to commercialize its unique and propriatary product series called TailorDose®. TailorDose® is a product line that meets the need for personalized cancer medicine relating to drugs that are difficult to dose, such as cyclophosphamide (CPA). The first product in this series is TailorDose®-CPA and is intended for cancer care in conditions such as breast cancer. There is a great medical need for personalized dosing of CPA. Our own clinical pilot study showed that over 35% of those treated with CPA received the wrong dose, and therefore did not get proper treatment. TailorDose® offers a solution for this problem. A single blood sample, followed by a quick analysis enables the physician to dose CPA correctly for each patient. 

Kategorier: Diagnostics

Gå till Adduct Analyss hemsida